Centene-WellCare Deal Is on Track for Approval; Combined Company Would Hold Nearly 20% of Medicaid Market

Centene Corp.’s planned acquisition of WellCare Health Plans, Inc., a $17 billion move that would create a managed Medicaid behemoth and a serious contender in the Medicare Advantage ring, is close to being a done deal. In December, the insurers received regulatory approval from the final states needed to move forward, bringing the total number to 27. The Department of Justice has yet to approve the deal, but Centene CEO Michael Neidorff on Dec. 5 informed attendees of the Forbes Healthcare Summit that he has “told the team to be ready for full integration by January 1,” and expects the deal to close in the first half of 2020. Not only will the combined company be No. 1 in Medicaid, with about 10.2 million enrollees (both Centene and WellCare are divesting their Medicaid plans in three state markets to ease antitrust concerns, see graphics below), it will also snag the No. 6 spot in the national MA market.

© 2024 MMIT
Carina Belles

Carina Belles

Carina has been covering public-sector health care since 2018. As a data reporter for Radar on Medicare Advantage, she creates infographics and data stories on issues impacting Medicare, Medicaid and Part D. She also develops AIS Health Daily, a free daily newsletter that showcases AIS’s strong reporting across our four publications and parent company Norstella’s suite of market access and data solutions. Prior to joining the editorial team, she managed Medicare and Medicaid data for the Directory of Health Plans, AIS’s industry-standard health coverage database. She graduated from Ohio University with a B.S. in Journalism.

Related Posts

charts
June 6

Aetna, Insurtechs Outpaced Medicare Advantage Peers in Quieter OEP

READ MORE
gavel-paperwork
June 6

FMO Lawsuits Could Delay Agent and Broker Compensation Rules

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
June 6

News Briefs: SCAN Wins Lawsuit Over 2024 Star Ratings Calculations

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today